Valion Bio raises $7.737 million via Series B/C preferred and warrants
Valion Bio entered a private placement letter agreement with 3i to issue Series B and Series C preferred shares with accompanying warrants for $7.737 million.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.